Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-207743
Filing Date
2019-07-31
Accepted
2019-07-31 06:58:37
Documents
78
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d771546d10q.htm 10-Q 1052999
2 EX-31.1 d771546dex311.htm EX-31.1 10408
3 EX-31.2 d771546dex312.htm EX-31.2 10387
4 EX-32.1 d771546dex321.htm EX-32.1 4651
5 EX-32.2 d771546dex322.htm EX-32.2 4495
  Complete submission text file 0001193125-19-207743.txt   5948861

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tbio-20190630.xml EX-101.INS 1252373
7 XBRL TAXONOMY EXTENSION SCHEMA tbio-20190630.xsd EX-101.SCH 53520
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbio-20190630_cal.xml EX-101.CAL 45009
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbio-20190630_def.xml EX-101.DEF 246597
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20190630_lab.xml EX-101.LAB 476950
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20190630_pre.xml EX-101.PRE 381005
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

EIN.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38550 | Film No.: 19987294
SIC: 2836 Biological Products, (No Diagnostic Substances)